PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Kordbacheh, T. [1 ,2 ]
Chan, C. [1 ]
Bossons, A. [2 ,3 ]
Franks, K. [4 ]
McDonald, F. [5 ]
Forster, M. [6 ]
Mendes, R. [7 ]
Quezada, S. [8 ]
Dovedi, S. [9 ]
Ralph, C. [10 ]
Popat, S. [11 ]
Harrington, K. [12 ,13 ]
Melcher, A. [14 ]
Popple, A. [9 ]
Illidge, T. [9 ]
Faivre-Finn, C. [1 ,2 ]
机构：
[1] Christie NHS Fdn Trust, Clin Oncol, Manchester, Lancs, England
[2] Univ Manchester, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Clin Trials Unit, Manchester, Lancs, England
[4] St James Univ Hosp, Leeds Canc Ctr, Clin Oncol, Leeds, W Yorkshire, England
[5] Royal Marsden NHS Fdn Trust, Clin Oncol, London, England
[6] UCL, Oncol, London, England
[7] Univ Coll London Hosp, Clin Oncol, London, England
[8] UCL Canc Inst, Immune Regulat & Tumour Immunotherapy, London, England
[9] Canc Res UK Manchester Inst, Targeted Therapy, Manchester, Lancs, England
[10] Univ Leeds, Leeds Immunotherapy Team, Leeds, W Yorkshire, England
[11] Royal Marsden Hosp, Lung Oncol Unit, London, England
[12] Royal Marsden NHS Fdn Trust, Clin Oncol, Targeted Therapy, Manchester, Lancs, England
[13] Inst Canc Res, Manchester, Lancs, England
[14] Inst Canc Res, Translat Immunol, Manchester, Lancs, England
来源：
LUNG CANCER | 2017年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
164
引用
收藏
页码：S75 / S76
页数：2
相关论文
共 50 条
  • [21] PD-1 antibody pembrolizumab administered at non-standard frequency in non-small cell lung cancer (NSCLC).
    Sehgal, Kartik
    Shea, Meghan
    McDonald, Danielle M.
    Huberman, Mark
    Weiss, Glen J.
    VanderLaan, Paul A.
    Costa, Daniel Botelho
    Rangachari, Deepa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Anti-PD-1 Combination Therapy as Second Line Treatment or Beyond in Patients with Advanced Non-Small Cell Lung Cancer
    Zhang, F.
    Huang, D.
    Li, L.
    Ma, J.
    Wang, J.
    Jiao, S.
    Hu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1055 - S1055
  • [23] The Efficacy and Safety of Anti-PD-1 in the Treatment of Non-Small Cell Lung Cancer (NSCLC): Systematic Review
    Di, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1917 - S1917
  • [24] Phase I Study of Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer
    Li, Bao-Sheng
    Gong, He-Yi
    Huang, Wei
    Yi, Yan
    Yu, Jin-Mimg
    Wang, Zhong-Tang
    Zhang, Zi-Cheng
    Sun, Hong-Fu
    Li, Hong-Sheng
    Wang, Li-Ying
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (02): : 115 - 119
  • [25] A phase I study of gemcitabine with concurrent radiotherapy in stage III, locally advanced non-small cell lung cancer
    van Putten, JWG
    Price, A
    van der Leest, AHD
    Gregor, A
    Little, FA
    Groen, HJM
    CLINICAL CANCER RESEARCH, 2003, 9 (07) : 2472 - 2477
  • [26] Phase I Study of Pemetrexed, Cisplatin, and Concurrent Radiotherapy in Patients with Locally Advanced Non-small Cell Lung Cancer
    Li, B.
    Yi, Y.
    Wang, Z.
    Sun, H.
    Gong, H.
    Zhang, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S464 - S465
  • [27] Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer
    Katz, Sharyn I.
    Hammer, Mark
    Bagley, Stephen J.
    Aggarwal, Charu
    Bauml, Joshua M.
    Thompson, Jeffrey C.
    Nachiappan, Arun C.
    Simone, Charles B., II
    Langer, Corey J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (07) : 978 - 986
  • [28] A Prospective Nonrandomized Phase I/II Study of Carbon Ion Radiotherapy in a Favorable Subset of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
    Takahashi, Wataru
    Nakajima, Mio
    Yamamoto, Naoyoshi
    Yamashita, Hideomi
    Nakagawa, Keiichi
    Miyamoto, Tadaaki
    Tsuji, Hiroshi
    Kamada, Tadashi
    Fujisawa, Takehiko
    CANCER, 2015, 121 (08) : 1321 - 1327
  • [29] Retreatment with anti-PD-1 antibody in non-small cell lung cancer patients previously treated with anti-PD-L1 antibody
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Hashimoto, Masayuki
    Nakatani, Koichi
    Sawai, Satoru
    Mio, Tadashi
    THORACIC CANCER, 2020, 11 (01) : 15 - 18
  • [30] A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer
    Yoshikazu Hasegawa
    Isamu Okamoto
    Ken Takezawa
    Masaaki Miyazaki
    Junji Tsurutani
    Kimio Yonesaka
    Ryotaroh Morinaga
    Asuka Tsuya
    Masaaki Terashima
    Toshihiro Kudoh
    Koichi Azuma
    Takayasu Kurata
    Tatsuyuki Nishikawa
    Masahiro Fukuoka
    Yasumasa Nishimura
    Kazuhiko Nakagawa
    Investigational New Drugs, 2013, 31 : 599 - 604
12345